what tirzepatide is approved for weight loss FDA approves new version of
Description
Maybe it reads 10mg/mL
Not for human consumption, nor medical, veterinary, or household uses
Tirzepatide weight loss results
The difference is the indication and dosing protocol
Weeks 3 to 4 represent the highest risk for blood sugar elevation as tirzepatide clears before semaglutide reaches full effect
Tirzepatide, the generic version of Mounjaro, is an FDA-approved antidiabetic medication used for the treatment of type 2 diabetes and has shown promising results in studies to help with weight loss even for people without diabetes
